Skip to main content

Table 1 Coagulation parameters.

From: Coagulation Disorders in Subjects Undergoing Pump-Driven Veno-Venous Ecco2-R For Severe Acute Hypercapnic Respiratory Failure - a Single Center Experience

 

baseline*

-72h

-48h

-24h

day of bleeding

hemoglobin (G/l)

114.5 ( ± 24.3)

97.8 ( ± 11.8)

88.8 ( ± 16.9)

79 ( ± 14.5)

81.8 ( ± 14.1)

thrombocytes (G/l)

195.5 ( ± 125.5)

193.3 ( ± 136.0)

171 ( ± 122.5)

141.8 ( ± 122.1)

125.5 ( ± 100.2)

fibrinogen (mg/dl)

370 ( ± 97.4)

358.8 ( ± 133.9)

343.5 ( ± 136.3)

255.5 ( ± 136.2)

235.5 ( ± 142.9)

AT III (%)

101 ( ± 20.9)

86 ( ± 25.7)

80.5 ( ± 21.6)

69.5 ( ± 23.7)

74 ( ± 14.5)

D-DIMER (µg/l)

1170 ( ± 435.4)

5079 ( ± 6597)

7569 ( ± 11340)

11048 ( ± 16140)

12709 ( ± 15453)

PT (%)

90.8 ( ± 18.7)

91 ( ± 19.8)

86.8 ( ± 18.8)

81.8 ( ± 16.9)

82.5 ( ± 24.8)

aPTT (sec)

38.8 ( ± 12.0)

39.8 ( ± 10.4)

46.8 ( ± 11.3)

49.5 ( ± 15.1)

36.8 ( ± 7.7)

Heparin (IU/kg/day)

0

207.8 ( ± 80.5)

259.7 ( ± 84.3)

150.1 ( ± 115.7)

78.33 ( ± 97.1)

  1. Results are presented as mean ( ± SD).
  2. *baseline refers to the last value before application of ECCO2-R